Hepatoprotective activity of 1,2,4-triazole-3-thione derivatives, which contains on C5 atomic carbon hydroxy(phenyl)methyl dependent
DOI:
https://doi.org/10.24959/ubphj.18.178Keywords:
1, 2, 4-triazole derivatives, hepatoprotective activity, carbontetrachloride, Alanine Aminotransferase, Aspartate AminotransferaseAbstract
Topicality. Actually it is very important to create highly effective but relatively inexpensive medications for the prevention and treatment the digestive system diseases. It would be appropriate to mention that we carried out an analysis of studies and examined hepatoprotective effects of 1,2,4-triazole derivatives, high rates of hepatoprotective effects were detected. Therefore, the search for hepatoprotectors in the series of 1,2,4-triazole derivatives has not only theoretical but also practical significance.
Aim. To study the first synthesized derivatives of 1,2,4-triazole-3-thione, containing substituents on C5 by carbon atom in conditions of tetrachormethane hepatitis.
Materials and methods. To model toxic hepatitis, a hepatotoxic xenobiotic, carbon tetrachloride, was used. The study of liver biochemical indicators was carried out in 24 hours later after the last injection of carbon tetrachloride. The ability of test compounds to restore the integrity of hepatocyte membranes was determined by anti-cytolytic effect (Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST) activity decrease). According to the results of the study, it was found that among 43 test compounds, 5 are able to prevent survival at 85.71 %.
Results and discussion. Thus, among the substances studied, compound 2c, which contributed 85.71 % of the survival of the experimental animals and decrease 33.43 % in ALT and 34.33 % in AST. In this case a very weak inverse dependence of the above was observed (r = -0.31).
Conclusions. As a result, some chemical structure patterns of the hepatoprotective action of 1,2,4-triazole derivatives were established, so the survival of the experimental animals decreased with the introduction of a phenyl substituent of the starting thiones with N4.
References
Matyashova, N. A., & Tkachova, O. V. (2017). Analysis of the range and social and economic availability of hepatoprotectors in Ukraine. Klìnìčna
Farmacìâ, 21 (1), 25–28. https://doi.org/10.24959/cphj.17.1417
Mykhailiuk, Ye. O. (2015). Farmakolohichna aktyvnist novykh pokhidnykh 4-R-5-(alkil-,aryl-, heteryl-)-1,2,4-triazolu pry eksperymentalnomu
toksychnomu hepatyti. Extendedabstract of candidate’s thesis. Zaporizhzhia, 22.
Popovych, V. P., Hromovyk, B. P., Hlukhovskyi, P. V. (2012). Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, 1 (8), 95–99.
Bilai, I., Mykhailiuk, Ye., Parchenko, V., Panasenko, O., Knysh, Ye. (2014). Ukraïns’kij bìofarmacevtičnij žurnal, 3 (32), 60–62.
Rajasekaran, A., & Periyasamy, M. (2010). Synthesis and evaluation of hepatoprotective activity of some new mannich bases bearing benztriazole
moiety. Journal of the Chilean Chemical Society, 55(3), 366–370. https://doi.org/10.4067/s0717-97072010000300021
Gubskii, Iu. I. (1982). Ukrainskii biokhimicheskii zhurnal, 54 (1), 46–50.
Stefanov, O. V. (2001). Doklinichni doslidzhennya likarskih zasobiv. Kyiv: Avitsena, 528.
Pozdniakov, B. C., Ivanov, N. G. (1979). Toksikologiia novykh promyshlennykh khim. veshchestv. M.: Meditcina, 87–90.
Reitman, S., & Frankel, S. (1957). A Colorimetric Method for the Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic Transaminases. American Journal of Clinical Pathology, 28(1), 56–63. https://doi.org/10.1093/ajcp/28.1.56
Vukolov, E. A. (2008). Osnovy statisticheskogo analiza. Praktikum po statisticheskim metodam i issledovaniiuoperatcii s ispolzovaniempaketov
STATISTICA i EXCEL : uchebnoe posobie. M.: Forum, 464.
Downloads
Published
Issue
Section
License
Copyright (c) 2018 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).